Position in CGC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$145,825
+$5,373 QoQ
Shares Held
153,500
+3.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 212 holders
Holding Since
Sep 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$254,505
PutShares
267,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $29,871,201 across 13 Drug Manufacturers - Specialty & Generic names. CGC ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
40,988 | $6,908,117 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
250,000 | $6,152,500 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
500,000 | $4,915,000 | |
| 4 | LQDA |
Liquidia Corp
|
45,233 | $3,606,427 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
97,363 | $3,375,575 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,675 | $1,991,225 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
15,000 | $1,664,100 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,500 | $479,625 |
All Filings in CGC
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,825 | 153,500 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $254,505 | 267,900 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $234,308 | 246,900 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $140,452 | 148,000 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $887,096 | 173,600 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $86,870 | 17,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $135,928 | 173,600 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $133,188 | 170,100 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $175,983 | 224,755 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $28,362 | 73,100 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $2,429,597 | 6,261,850 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $29,526 | 76,100 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $127,925 | 73,100 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $133,175 | 76,100 | Put | Sole | 2023-05-15 | |
| 2021-09-30 | $358,211 | 25,845 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||